Search by Drug Name or NDC
NDC 59212-0001-02 Dibenzyline 10 mg/1 Details
Dibenzyline 10 mg/1
Dibenzyline is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is PHENOXYBENZAMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phenoxybenzamine is used to treat episodes of high blood pressure and sweating related to pheochromocytoma. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 59212-0001-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Phenoxybenzamine
Product Information
| NDC | 59212-0001 |
|---|---|
| Product ID | 59212-001_c124072c-1f16-4359-942d-e48a3b593ff2 |
| Associated GPIs | 36300010100105 |
| GCN Sequence Number | 005108 |
| GCN Sequence Number Description | phenoxybenzamine HCl CAPSULE 10 MG ORAL |
| HIC3 | J7B |
| HIC3 Description | ALPHA-ADRENERGIC BLOCKING AGENTS |
| GCN | 20540 |
| HICL Sequence Number | 002098 |
| HICL Sequence Number Description | PHENOXYBENZAMINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | Dibenzyline |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Phenoxybenzamine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENOXYBENZAMINE HYDROCHLORIDE |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA008708 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59212-0001-02 (59212000102)
| NDC Package Code | 59212-001-02 |
|---|---|
| Billing NDC | 59212000102 |
| Package | 100 CAPSULE in 1 BOTTLE (59212-001-02) |
| Marketing Start Date | 2020-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |